- The MARCOPOLO Study of Ustekinumab Utilization and Efficacy in a Real-World Setting: Treatment of Patients with Plaque Psoriasis in Asia-Pacific Countries
-
Youn SW, Tsai TF, Theng C, Choon SE, Wiryadi BE, Pires A, Tan W, Lee MG, MARCOPOLO Investigators
- KMID: 2171381
- Ann Dermatol.
- 2016 Apr;28(2):222-231.
- doi: 10.5021/ad.2016.28.2.222
BACKGROUND: Ustekinumab is a fully human monoclonal antibody approved for the treatment of chronic moderate-to-severe plaque psoriasis in adults. However, factors including efficacy, tolerability, ease of use, and cost burden... -
- CITED
-
- Close
- SHARE
-
- Close
